Companies

Intercell Receives Approval for Vaccine in India

Published: November 10, 2011; 18:52 · (Vindobona)

The Austrian pharmaceutical company achieved an important milestone in the roll-out of its Japanese Encephalitis vaccine in endemic countries.

Intercell Receives Approval for Vaccine in India / Picture: © Intercell

Intercell AG and its partner Biological E. Ltd. today announced the approval of their vaccine to protect children and adults from Japanese Encephalitis (JE) by the Drugs Controller General of India (DCGI).

As previously announced, the analysis of the pivotal Phase III safety and immunogenicity data showed positive results and the study met its primary endpoint. Through a rolling…

This article includes a total of 227 words.

or Log In

Fast News Search

Join us to succeed in Vienna! Sign up to read articles for free and to get personalized updates on the events that interest you.

Intercell Receives Approval for Vaccine in India

The Austrian pharmaceutical company achieved an important milestone in the roll-out of its Japanese Encephalitis vaccine in endemic countries.

Join us to succeed in Vienna!
Sign up to read articles for free and to get personalized updates on the events that interest you.